
This book provides insight into the various immunotherapeutic approaches for the treatment of lung cancers. The chapters of the book discuss the detailed mechanisms of checkpoint inhibitors, co-stimulatory molecules, drugs working in the immunosuppressive environment, and various vaccines for lung cancer. A chapter of the book explores the recent applications of the oncolytic virus in lung cancer treatment and discusses the potential and direction of oncolytic virus-based therapeutic vaccines. The chapter also elucidates the current understanding of the role of Toll-Like Receptors (TLRs) in tumor progression, and the recent progress in utilizing TLR agonists as potential therapeutic agents in lung cancer treatment. Towards the end, the book reviews the applications of stereotactic body radiation therapy (SBRT) and immunotherapy for the treatment of lung cancer. This book provides useful information to a range of audiences including clinical researchers working in the field of lung cancer, and undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences.
Inhaltsverzeichnis
Chapter 1_
An introduction to Lung cancer. -
Chapter 2_
Immunobiology of Lung cancer. -
Chapter 3_
Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy. -
Chapter 4_
Recent advances in the immunotherapy of Lung cancer. -
Chapter 5_
PD-1/PD-L1 inhibitors for the treatment of Lung cancer. -
Chapter 6_
CTLA-4 inhibitors for the treatment of Lung cancer. -
Chapter 7_
Adoptive T cell therapy for the treatment of Lung cancer. -
Chapter 8_
LAG-3 inhibitors for the treatment of Lung cancer. -
Chapter 9_
IDO and TGF-ß inhibitors for the treatment of Lung cancer. -
Chapter 10_
OX40 and CD40 agonists for the treatment of Lung cancer. -
Chapter 11_
ICOS and GITR agonists for the treatment of Lung cancer. -
Chapter 12_
Vaccines and oncolytic virus for the treatment of Lung cancer. -
Chapter 13_
Targeting Toll-like receptors for the treatment of Lung cancer. -
Chapter 14_
Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy. -
Chapter 15_
Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer. -
Chapter 16_
Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer. -
Chapter 17_
Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer. -
Chapter 18_
Insight on the clinical trials of immunotherapy for the treatment of Lung cancer. -
Chapter 19_
Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.
Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Immunotherapy Against Lung Cancer" und helfen Sie damit anderen bei der Kaufentscheidung.